The Premier Consulting Blog

DECEMBER 28, 2023

3] Understanding Medicare Coverage for IDE Studies The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) allows for Medicare coverage of the routine costs of care provided to Medicare beneficiaries in certain categories of Investigational Device Exemption (IDE) studies. [4] 5] US Food and Drug Administration.

Regulations 52

Regulations FDA Packaging Clinical Trials 52

The Pharma Data

MARCH 26, 2021

This CHMP opinion follows the recent label expansion by the US Food and Drug Administration to include LN. Make patients aware of potential risk of hypersensitivity reactions (day of, or several days after infusion, including signs/symptoms and recurrence) and provide package leaflet each time Benlysta administered.

Therapies 52

Therapies Disease Treatment Vaccine 52

Agency IQ

APRIL 8, 2024

When the document was taken back to the drawing board again in 2003, it remained on hold for more than a decade until a final version was agreed upon in 2012, with the FDA officially adopting it in 2014. While the SRP could be used to submit information on drugs and biological products, the only exception was for vaccines.

FDA 40

FDA Production Regulations Vaccine 40

Agency IQ

JUNE 7, 2024

The directives also had special scopes describing, for example, devices incorporating drugs, IVDs and medical devices in sterile condition, etc. There are two codes that all 49 Notified Bodies received designation to – devices with a measuring function (MDS 1010) and devices that require packaging/labeling (MDT 2011).

Regulations 40

Regulations Compliance Packaging Production 40

Agency IQ

JUNE 2, 2023

FDA unveils long-awaited Patient Medication Information proposed rule Since 2017, the FDA has been working on a proposal to create a new type of patient-focused labeling for certain outpatient drug products that would be specifically targeted for patient use. The FDA recently concluded its work on a proposed rule focused on PMI.

FDA 40

FDA FDA Approval Regulations Production 40

Agency IQ

OCTOBER 27, 2023

The current Primary Magnesium Refining NESHAP was promulgated pursuant to CAA section 112(d) on October 10, 2003. The Rubber Tire Manufacturing NESHAP, subpart XXXX, was promulgated pursuant to section 112(d) of the Clean Air Act (CAA) on July 9, 2002, with corrections promulgated on March 12, 2003.

Regulations 40

Regulations Compliance Science Production 40

Agency IQ

DECEMBER 1, 2023

The current Primary Magnesium Refining NESHAP was promulgated pursuant to CAA section 112(d) on October 10, 2003. This package would propose updates to the alternative work practice as appropriate based on the review and address the issues raised for reconsideration. 2020) (LEAN).

Regulations 40

Regulations Production Compliance Science 40